Companies›Healthcare›Healthcare›Healthcare Services
NSE:MEDANTA

GLOBAL HEALTH LIMITED

Healthcare › Healthcare Services·NIFTY 500NIFTY LARGEMIDCAP 250NIFTY MIDCAP 150NIFTY MIDSMALLCAP 400+6
₹1,260.00
at close · 27 Oct 2026
▲ 49.30 (+4.07%)

Latest filings

Next results: Tue, 3 Nov · Financial Results
  1. Medanta schedules Q2 FY2027 earnings call for November 4 · Board & Shareholder Meetings
  2. Global Health allots 2,750 shares under employee incentive plan · Capital Market Events
  3. Board meeting on Nov 3, 2026 to approve Q2 and H1 FY26-27 results · Results
All filings ↓
Ask Nexa about GLOBAL HEALTH LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates multi-specialty hospitals under the Medanta brand, providing inpatient and outpatient clinical care across facilities in India. As of March 31, 2026, the network runs 6 hospitals with 3,665 installed beds, with 5 additional hospitals in the pipeline. Revenue is generated from patient services — hospitalisation, surgeries, consultations and diagnostics — and is split between mature hospitals (such as the Gurugram flagship) and developing units (Lucknow, Patna, Noida). In Q1 FY26, mature hospitals delivered total income of ₹7,006 mn at 23.4% EBITDA margin, while developing hospitals (Lucknow, Patna) delivered ₹3,219 mn at 29.3% margin with 64% occupancy. International patient revenue from CIS, Africa and Southeast Asia rebounded 34% YoY in Q1 FY26. The group has a 2,000-bed expansion pipeline over 3-4 years, including a 550-bed Noida hospital (opened November 2025), a 110-bed Ranchi unit (July 2025) and a Guwahati hospital scaled up to 650 beds, with FY27 capex guided at ₹800-900 crore. Employee expenses (24.9% of revenue) and materials consumed (20.0% of revenue) are the largest cost lines.

Operating scale
Hospitals in operation
6 hospitalsMarch 31, 2026
Installed beds
3,665 bedsMarch 31, 2026
ARPOB (hospital network)
₹66,584Q1 FY26
Mature hospital ARPOB
₹73,256Q1 FY26
Bed occupancy
~63%Q1 FY26
Bed expansion pipeline
2,000 beds over 3-4 yearsFY26-FY30
Who pays it
Hospital patients — predominantly Indian, with international patients from CIS, Africa and Southeast Asia
Biggest cost
Employee costs (24.9% of revenue) covering doctors, nurses and clinical staff
Kind of business
Asset-heavy multi-specialty hospital network in expansion mode
Where it sits
Multi-specialty hospital operator in India with a Gurugram flagship and 5 upcoming hospitals in the pipeline
Market Cap
₹33,865 Cr
P / E (TTM)
60.9×
EV / EBITDA
33.0×
Div Yield
0.04%
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
15.0%▲
ROCE (FY26)
ROE 13.9% · margin 23.1%
Leverage
0.30·
Debt / Equity · low
Net debt ₹1,063 Cr
Revenue FY23→FY26
1.6×▲
Margin +0.5 pts
₹2,694 Cr → ₹4,410 Cr
Cash conversion
1.41×▲
Operating cash ÷ profit · 4 yrs
₹2,595 Cr on ₹1,840 Cr
Moves on a normal day
1.21%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 29 Hospital peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#25/30
P/B#21/24
ROCE#10/30
ROE#8/24
Debt / Equity#16/24
EBITDA margin#11/24
Revenue growth#7/23
Profit growth#17/21

Scorecard

Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice

Strengths
Returns on capital 15.0%
#10 of 30 in Hospital on the latest reported figures
Over 4 years it reported ₹1,840 Cr of profit and ₹2,595 Cr of operating cash — 1.41×
Profit is converting into cash
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

MEDANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from GLOBAL HEALTH LIMITED's filed financials and exchange disclosures

What does GLOBAL HEALTH LIMITED do?

GLOBAL HEALTH LIMITED is a Healthcare Services company listed on NSE and BSE, trading under the symbol MEDANTA.

Is GLOBAL HEALTH LIMITED profitable?

Yes. Over the trailing twelve months GLOBAL HEALTH LIMITED reported a net profit of ₹552 Cr on revenue of ₹4,683 Cr.

Does GLOBAL HEALTH LIMITED pay a dividend?

Yes. The dividend yield is 0.04% at the current price. It paid out 2% of its profit as dividend in FY26.

Is GLOBAL HEALTH LIMITED debt-free?

No. It reported borrowings of ₹1,190 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹1,063 Cr after cash. Debt stands at 0.30× equity. That is higher than 65% of its 24 Hospital peers.

Is GLOBAL HEALTH LIMITED expensive compared with its peers?

On trailing P/E, GLOBAL HEALTH LIMITED ranks 25 of 30 in Hospital — cheaper than 17% of them, against an industry median of 42.2×. This is a position, not a valuation judgement.

How much does the GLOBAL HEALTH LIMITED share price move in a day?

On a typical session GLOBAL HEALTH LIMITED moves 1.21% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

When are GLOBAL HEALTH LIMITED's next results?

Financial Results on Tue, 3 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track GLOBAL HEALTH LIMITED's announcements?

Every NSE and BSE filing by GLOBAL HEALTH LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.